How pharma companies can make sure their corporate strategy in ESG is appealing to younger generations—and aligns with the issues this large segment of sustainability investors care about most.
Terry Branstad
Advertisement
Articles by Terry Branstad
Advertisement
Latest Updated Articles
Elevating ESG Message: Today’s Modern Investor is KeyAugust 17th 2022
Advertisement
Advertisement
Trending on PharmExec
1
Prediction Markets Expose a Gap in Pharmaceutical Vendor Contracts
2
Roundup: Rona Therapeutics Enters Global License Agreement for ALK7-targeting RNAi Therapy, Enodia Therapeutics Enters Collaboration and License Agreement to Develop Sec61-Targeting Small Molecules
3
The Bottlenecks That Slow Manufacturer Response to Increased Demand for Production
4
Pharmaceutical Executive Daily: Rona Therapeutics Enters Global License Agreement for ALK7-targeting RNAi Therapy with Roche
5